International Private Wealth Advisors LLC boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 14.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 14,730 shares of the pharmacy operator’s stock after buying an additional 1,870 shares during the period. International Private Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $137,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of WBA. First Financial Corp IN grew its position in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. TD Private Client Wealth LLC raised its position in shares of Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 3,208 shares during the last quarter. Sentry Investment Management LLC purchased a new position in shares of Walgreens Boots Alliance in the third quarter worth $30,000. Finally, Eastern Bank purchased a new position in Walgreens Boots Alliance during the third quarter valued at $33,000. 58.59% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have commented on WBA. Jefferies Financial Group dropped their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Bank of America increased their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Finally, UBS Group boosted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $13.19.
Walgreens Boots Alliance Stock Down 1.5 %
NASDAQ WBA opened at $9.97 on Tuesday. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.96. The company’s 50-day moving average price is $10.22 and its 200-day moving average price is $9.80. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter in the previous year, the firm posted $0.66 earnings per share. The company’s revenue was up 7.6% on a year-over-year basis. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
- Five stocks we like better than Walgreens Boots Alliance
- What Investors Need to Know to Beat the Market
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What is a Death Cross in Stocks?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.